Azenta
AZTA | NASDAQ
$47.22
+$1.57 (+3.44%)
At close: Nov 16, 2026, 4:00 PM ET
$47.22
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Azenta Company Profile
Company profile explainedCompany Profile
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| Martin D. Madaus | Interim President, CEO & Director |
| Lawrence Y. Lin | Executive Vice President & Chief Financial Officer |
| Alex Esmon | Vice President and General Manager of Sample Repository Solutions |
| Andrea O'Hara | Strategic Technical Specialist of Azenta Life Sciences |
| Ephraim Starr | Senior Vice President, General Counsel & Corporate Secretary |
| Erik J. Bello | Vice President, Chief Accounting Officer & Principal Accounting Officer |
| Ginger Zhou | Advisor |
| Michael Paulo | Vice President, Chief Information & Digital Officer |
| Olga Pirogova | Senior Vice President & Chief HR Officer |
| William E. Martin | Senior Vice President & President of Multiomics |
| Yvonne Perron | Vice President of Financial Planning & Analysis and Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | 8-K | Current Report |
| Oct 23, 2026 | 4 | Filing |
| Oct 07, 2026 | 8-K | Current Report |
| Sep 23, 2026 | 4 | Filing |
| Sep 17, 2026 | 8-K | Current Report |
| Sep 16, 2026 | 4 | Filing |
| Sep 16, 2026 | 4 | Filing |
| Sep 16, 2026 | 4 | Filing |
| Sep 16, 2026 | 4 | Filing |
| Sep 16, 2026 | 4 | Filing |
Azenta
| Country | United States |
| IPO Date | Feb 2, 1995 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 2,900 |
| CEO | Martin D. Madaus |
Contact Details
200 Summit Drive Burlington,
Massachusetts 01803 United States
Stock Details
| Ticker Symbol | AZTA |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0000933974 |
| CUSIP Number | 114340102 |
| ISIN Number | US1143401024 |
| SIC Code | 3559 |
Recent News
- 5 days ago / fool.comWhy Azenta Stock Crushed it on Wednesday
- 5 days ago / marketbeat.comWhat Azenta (AZTA) Said on Its Q4 Earnings Call
- 5 days ago / seekingalpha.comAzenta, Inc. (AZTA) Q4 2026 Earnings Call Transcript
- 6 days ago / prnewswire.comAzenta Reports Fourth Quarter and Full Year Results for Fiscal 2026, Ended September 30, 2026.
- 14 days ago / seekingalpha.comAzenta: A Sample Custody Annuity Priced Like A Broken Equipment Vendor
- 18 days ago / prnewswire.comAzenta Announces Strategic Investments to Advance the Next Generation of GENEWIZ Gene Synthesis Capabilities
- 19 days ago / prnewswire.comAzenta Announces Fiscal 2026 Fourth Quarter and Full Year Conference Call and Webcast
- 1 month ago / gurufocus.comAzenta Inc (AZTA) Shares Fall 7.9% -- What GF Score of 83 Tells Investors
- 2 months ago / prnewswire.comAzenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems
- 3 months ago / prnewswire.comAZENTA ANNOUNCES LEADERSHIP TRANSITION
Add to Watchlist
Select watchlists to add or remove AZTA